$KERX Recent News Six stocks to watch 1:47 p.m. Aug.

New Post Public Reply Private Reply Replies (0) Message Board

Sep 18, 2014 at 10:07 AM

$KERX Recent News

Six stocks to watch 1:47 p.m. Aug. 27, 2014 - The Trading Deck
When it rains, it pours for Nasdaq leadership 12:47 p.m. March 27, 2014 - The Trading Deck
Six stocks to watch 4:27 p.m. Feb. 26, 2014 - The Trading Deck
Nasdaq extends break to less-charted territory 12:42 p.m. Dec. 2, 2013 - Michael Ashbaugh
6 movers to watch 3:08 p.m. Nov. 6, 2013 - The Trading Deck
Keryx climbs after treatment shows positive result 11:01 a.m. Nov. 5, 2013 - MarketWatch.com
Six stocks to watch for some upside 3:21 p.m. April 11, 2013 - The Trading Deck
6 gut checks before the stock market's opening bell 7:47 a.m. March 7, 2013 - Shawn Langlois
Towerstream, Vanguard and others price offerings 11:32 a.m. Jan. 31, 2013 - MarketWatch.com
6 gut checks before the stock market's opening bell 7:52 a.m. Jan. 31, 2013 - Shawn Langlois
Keryx Biopharmaceuticals up 8.5% in premarket 8:58 a.m. Jan. 29, 2013 - Steve Gelsi
Monday’s movers: Herbalife clobbered on FTC news 5:30 p.m. Jan. 28, 2013 - Sue Chang
In focus: No letup by the bulls 8:45 p.m. Jan. 23, 2013 - Lawrence G. McMillan
Keryx Biopharma rises 17% in premarket trades 8:36 a.m. Jan. 23, 2013 - Steve Gelsi
Monday’s biggest gaining and declining stocks 4:37 p.m. April 23, 2012 - MarketWatch
Monday’s biggest gaining & declining stocks 5:56 p.m. April 2, 2012 - Kate Gibson
Keryx, AEterna implode on failed drug study 11:13 a.m. April 2, 2012 - Val Brickates Kennedy
Keryx, AEterna rally ahead of study results 1:34 p.m. March 16, 2012 - Val Brickates Kennedy
Keryx , AEterna rally ahead of study results 1:32 p.m. March 16, 2012 - Val Brickates Kennedy
Top longs and shorts to watch 1:18 p.m. March 6, 2012 - The Trading Deck

SEC Slaps Biotech Hedge Fund for Short-Selling Violations 1:04 p.m. Sept. 16, 2014 - TheStreet.com
If Achillion's Hep C Nucleotide Isn't Best In Class, The Stock Is Worth Low Single Digits 8:00 a.m. Sept. 16, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – ISIS PBYI KERX HALO 1:30 p.m. Sept. 11, 2014 - InvestorPlace.com
Insider Trading Alert - DVA, DATA And KERX Traded By Insiders 10:30 a.m. Sept. 11, 2014 - TheStreet.com
Biotech Stock Roundup: AbbVie Ties Up with Infinity, Keryx Slips on FDA Approval - Analyst Blog 11:17 a.m. Sept. 10, 2014 - Zacks.com
Keryx Biopharmaceuticals (KERX) Weak On High Volume Today 10:02 a.m. Sept. 10, 2014 - TheStreet.com
Keryx Biopharmaceuticals (KERX) Is Today's Roof Leaker Stock 1:34 p.m. Sept. 9, 2014 - TheStreet.com
Keryx's FDA Approval a Mixed Bag 7:47 a.m. Sept. 9, 2014 - Barrons.com
Deutsche Bank’s 4 Top Biotech Stocks to Buy for This Year and 2015 7:44 a.m. Sept. 9, 2014 - 247WallSt.com
Keryx Falls after Ferric Citrate's Approval with Warnings - Analyst Blog 6:05 p.m. Sept. 8, 2014 - Zacks.com
Silver Spring Networks Starts The Week Strong 1:30 p.m. Sept. 8, 2014 - TheStreet.com
Keryx Biopharmaceuticals' (KERX) CEO Ron Bentsur Discusses the approval of Ferric Citrate (Transcript) 1:18 p.m. Sept. 8, 2014 - Seeking Alpha
Keryx Biopharmaceuticals' (KERX) CEO Ron Bentsur Discusses FDA approval of Ferric Citrate (Transcript) 1:18 p.m. Sept. 8, 2014 - Seeking Alpha
Why Keryx Biopharmaceuticals (KERX) Stock Is Falling Today 11:25 a.m. Sept. 8, 2014 - TheStreet.com
Keryx Falls Victim To A Self-Fulfilling Prophecy, Creates Opportunity 10:05 a.m. Sept. 8, 2014 - Seeking Alpha
Keryx Biopharmaceuticals (KERX) Crumbles: Stock Falls by 5.5% - Tale of the Tape 8:55 a.m. Sept. 8, 2014 - Zacks.com
Analysts' Actions: AIG, Bank of America, Ford, FireEye and More 8:27 a.m. Sept. 8, 2014 - TheStreet.com
Top Analyst Upgrades and Downgrades: Altria, BofA, FireEye, Ford, J.P. Morgan, Linn Energy and More 7:51 a.m. Sept. 8, 2014 - 247WallSt.com
Keryx Bear Case Bolstered by Less-Than-Zippy 'Zerenex' Label 7:00 a.m. Sept. 8, 2014 - TheStreet.com
Keryx Finds Out That Not All FDA Approvals Are Wins 2:17 p.m. Sept. 5, 2014 - 247WallSt.com

Market Activity, Drug Approval, Upcoming Conference, and Presentation of Clinical Data - Research Reports on Jazz, Keryx, Vertex, WellPoint and GSK 9:15 a.m. Sept. 10, 2014 - PR Newswire - PRF
Biotech Stocks Under Review -- Keryx Biopharma, Sangamo BioSciences, Regeneron Pharma, Sunesis Pharma, and Idera Pharma 9:10 a.m. Sept. 9, 2014 - PR Newswire - PRF
Keryx Biopharmaceuticals, Inc. to Present at the Rodman & Renshaw 16th Annual Global Investment Conference 4:01 p.m. Sept. 5, 2014 - GlobeNewswire
Keryx Biopharmaceuticals Receives FDA Approval of Ferric Citrate, a New, Oral Iron-Based Treatment for Dialysis Patients With Hyperphosphatemia 11:41 a.m. Sept. 5, 2014 - Thomson Reuters ONE
Keryx Biopharmaceuticals Receives FDA Approval of Ferric Citrate, a New, Oral Iron-Based Treatment for Dialysis Patients With Hyperphosphatemia 11:19 a.m. Sept. 5, 2014 - GlobeNewswire
Keryx Biopharmaceuticals, Inc. Announces Second Quarter and Six Month 2014 Financial Results 7:02 a.m. Aug. 7, 2014 - GlobeNewswire
Biotech Equities Roundup -- Keryx Biopharma, Vertex Pharma, NPS Pharma, Cubist Pharma, and Idera Pharma 8:50 a.m. Aug. 6, 2014 - PR Newswire - PRF
Keryx Biopharmaceuticals, Inc. to Host Conference Call on Second Quarter 2014 Financial Results 8:02 a.m. Aug. 5, 2014 - GlobeNewswire
Conference Call Schedules, Publication of Study Results, and Public Offer Pricing - Research Reports on Medivation, Keryx, Amicus, AGTC and Clovis 8:50 a.m. July 30, 2014 - PR Newswire - PRF
Zerenex(TM) (Ferric Citrate) Long-Term Phase 3 Study Results Published in the Journal of the American Society of Nephrology 5:01 p.m. July 24, 2014 - GlobeNewswire
Zerenex(TM) (Ferric Citrate) Long-Term Phase 3 Study Results Published in the Journal of the American Society of Nephrology 5:00 p.m. July 24, 2014 - Thomson Reuters ONE
Leadership Appointments, Earnings Conference Calls, Milestone Payments, and Technical Updates - Analyst Notes on Illumina, Alexion, Incyte, Clovis and Keryx 8:10 a.m. July 17, 2014 - PR Newswire - PRF
Patent Issuance, Positive Trial Data, Recognitions, and Priority Review - Analyst Notes on Keryx, Puma, Ligand, Sagent and Enanta 7:50 a.m. June 30, 2014 - PR Newswire - PRF
Health Care Sector Equities Technical Coverage -- Research on Keryx Biopharma, Thoratec, Unilife, and VIVUS 7:10 a.m. June 30, 2014 - PR Newswire - PRF
Keryx Biopharmaceuticals Announces Issuance of Two U.S. Patents for Zerenex(TM) Covering Orally Administrable Forms of Ferric Citrate 8:31 a.m. June 18, 2014 - GlobeNewswire
Keryx Biopharmaceuticals Announces Issuance of Two U.S. Patents for Zerenex(TM) Covering Orally Administrable Forms of Ferric Citrate 8:31 a.m. June 18, 2014 - Thomson Reuters ONE
Keryx Biopharmaceuticals, Inc. to Present at the 9th Annual JMP Securities Healthcare Conference 4:30 p.m. June 17, 2014 - GlobeNewswire
Trial Results, Patient Enrollment, and Strategic Collaborations - Analyst Notes on Alnylam, Celldex, Keryx, Spectrum and MacroGenics 5:20 a.m. June 12, 2014 - PR Newswire - PRF
Keryx Biopharmaceuticals, Inc. to Present at the 35th Annual Goldman Sachs Global Healthcare Conference 8:34 a.m. June 5, 2014 - GlobeNewswire
Pre-Market Review on Biotechnology Equities -- Research on BioMarin Pharma, Keryx Biopharma, Amgen, and Peregrine Pharma 8:30 a.m. May 30, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top Tax Expert Holly Paz Joins alliant's Elite Team

Big Leagues in Tax: Holly Paz Joins alliant Tax is one of those fields that's not for the faint of heart. It's complex, ever-changing, and can make or break businesses. Enter Holly Paz, once at the helm of the IRS's Large Business & International Division, now bringing her vast experience to alliant. Paz is a bona fide heavyweight in tax administration, and her arrival at...

ASUR Scales Up: Acquires 20 Latin American Airports

A Bold Move in a Competitive Market I'll tell you, it's not every day you see a company like Grupo Aeroportuario del Sureste, S.A.B. de C.V. (NYSE: ASR) make a nearly billion-dollar move. This ain't some pocket change acquisition. We're talking about sealing the deal for Motiva's interests—R$5.1 billion (or nearly $992 million USD) to grab 20 airports in Brazil,...

Leopard Imaging's DragonFire Aims at Industrial Heat Tracking

DragonFire: A New Player in Industrial Thermal Imaging Leopard Imaging is strutting onto the thermal imaging stage with a fresh piece of tech—DragonFire. Now, this ain't just another gadget in a long line of gizmos. Unlike your run-of-the-mill cameras, this one packs a punch with its high-resolution uncooled infrared capability. Imagine the kind of precision you can...

Fibocom's RU311: Navigating 5G's Mid-Tier Maze

Cracking Open the RU311 Phenomenon Technology must evolve with purpose. This time around, Fibocom's RU311 module series steps up to the plate, delivering a tailored solution in the 5G landscape for the mid-tier IoT devices that need more than just speed. Beyond Raw Bandwidth: What Really Matters Plenty of folks out there still chase the elusive thrill of higher speeds as...

MEGA SHOW 2026: Asia's Premier Sourcing Powerhouse

MEGA SHOW 2026: Where Asian Sourcing Dreams Come True Anything worthwhile demands a veteran’s eye and a seasoned gut feeling. Swapping tales of the pavement or sifting through digital noise has me biting into MEGA SHOW Hong Kong 2026, an annual heavyweight event that stands as a prime stop on the autumn calendar for industry movers and shakers. We've circled back to the...

Student Mobility and Education: A Vital Intersection

Ritu Narayan’s Book Sparks a Vital Conversation They say never judge a book by its cover, but Ritu Narayan’s newly crowned bestseller, The Most Important Commute, begs us to look beyond the page: it's the saga of a bus ride, as mundane as rain until you peel back the layers of what it means for education today. Could something as seemingly simple as a school bus ride...

Edgewell Prepares for Key Discussion at Barclays Conference

Upcoming Fireside Chat: Edgewell's Moment of Candor Alright, folks, Edgewell Personal Care Company is about to sit in a hot seat, at the Barclays 19th Annual Global Consumer Conference. You know the deal, it’s where big shots like Rod Little, the President and CEO, and Fran Weissman, the CFO, spill the beans about where the company might be headed next. Hold on to your...

Skanska's $57M Deal to Transform Del Mar Traffic

A Roadway Overhaul in Del Mar A cool $57 million. That’s the ticket Skanska bought to scoop up the El Camino Real project in Del Mar, California. Think of it as a road facelift, a necessary one—it includes bulking up the corridor to four lanes and swapping in a spanking new San Dieguito River Bridge, taking the place of an old rascal that's been around for 84 years....

OCI Energy and Arava Power Ignite SunRoper Solar Project

Bridging Houston's Energy Gap with New Solar Power There's a new player in town aiming to meet the growing electricity demand in the Houston area. On September 1, 2026, OCI Energy and Arava Power, along with their project partners, broke ground on the SunRoper Solar project in Wharton County, Texas. This isn't just any solar venture; it's a hefty 347 MWdc facility that's...

York Space Systems Faces Class Action After IPO Issues

What's Up with York Space Systems? Alright, let's dive straight into this unfolding drama. York Space Systems—fresh off their IPO in January 2026—is now neck-deep in a class action lawsuit courtesy of Robbins LLP. It's a heavy hitter for folks who put money into their stock under the assumption that it was as solid as a rock. Instead, there seems to be a soft...